Dr. Reddy’s (DRL) has launched Palonosetron Hydrochloride injection, a therapeutic equivalent generic version of Aloxi (palonosetron hydrochloride) injection approved by the US Food and Drug Administration (USFDA).The Aloxi brand and generic had US sales of approximately $446 million for the most recent 12 months ending in January 2018, according to IMS Health.
CapitalStars Award Winning , SEBI registered , ISO certified investment advisory company. We provide intraday & positional services in Equity , derivative ,commodity & currency. Our research is highly skilled & experienced .
Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
No comments:
Post a Comment